Orthofix Medical Inc.
OFIX
NASDAQ·Healthcare·Medical - Devices·Mkt cap $375.5M
$9.29
▼ -0.21%
P/E
-6.05
Mkt Cap
$375.5M
52-Wk Range
$8.85–$16.99
52-Week Range
$8.85 - $16.99
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 36.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary bone growth stimulation technology with established clinical efficacy
- Diversified product portfolio spanning spine and orthopedic markets reduces revenue concentration
- Global distribution infrastructure with direct sales presence in key markets
- Regenerative medicine and synthetic biologic capabilities differentiate from traditional implant competitors
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging global population increasing demand for spine and orthopedic surgical procedures
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Stable
-4.1% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying OFIX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 5, 2026
Reported EPS of -$0.39 vs -$0.41 consensus (+4.8% surprise). Revenue of $210.9M vs $209.3M expected (+0.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+4.8%
Revenue trend · last 8Q
—
+8%
+3%
+2%
+5%
+2%
+2%
+4%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$196.6M
$215.7M
$193.6M
$203.1M
$205.6M
$219.9M
$196.7M
$210.9M
Margins · last 8Q
Gross
71.0%
Operating
-2.0%
Profit
-7.5%
Wall Street consensus
4 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Aug 6, 2026
vs Industry
How OFIX stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related